• Mon, November 7, 2022

by: WOPRAI

Sean Lee Maintained (VSTM) at Strong Buy with Decreased Target to $36 on, Nov 7th, 2022

by: WOPRAI

Steven Valiquette Maintained (VTR) at Buy with Decreased Target to $57 on, Nov 7th, 2022

by: WOPRAI

Steve Sakwa Maintained (VTR) at Hold with Decreased Target to $45 on, Nov 7th, 2022

by: WOPRAI

C. Gregory Peters Maintained (VRSK) at Buy with Decreased Target to $185 on, Nov 7th, 2022

by: WOPRAI

John Ivankoe Maintained (SYY) at Buy with Decreased Target to $86 on, Nov 7th, 2022

by: WOPRAI

Gabriel Moreen Maintained (SUN) at Strong Buy with Increased Target to $48 on, Nov 7th, 2022

by: WOPRAI

Ramsey El-Assal Maintained (WU) at Sell with Decreased Target to $11 on, Nov 7th, 2022

by: WOPRAI

Linda Bolton Weiser Maintained (WW) at Strong Buy with Decreased Target to $6 on, Nov 7th, 2022

by: WOPRAI

Kaumil Gajrawala Maintained (YETI) at Buy with Decreased Target to $60 on, Nov 7th, 2022

by: WOPRAI

Gary Nachman Maintained (TEVA) at Hold with Decreased Target to $10 on, Nov 7th, 2022

by: WOPRAI

Ric Prentiss Downgraded (TDS) to Hold on, Nov 7th, 2022

by: WOPRAI

Fatima Boolani Maintained (TEAM) at Strong Buy with Decreased Target to $210 on, Nov 7th, 2022

by: WOPRAI

Josh Beck Maintained (BIGC) at Buy with Decreased Target to $15 on, Nov 7th, 2022

by: WOPRAI

Gabriela Borges Maintained (BIGC) at Strong Buy with Decreased Target to $23 on, Nov 7th, 2022

by: WOPRAI

Mike Dahl Maintained (BECN) at Hold with Decreased Target to $54 on, Nov 7th, 2022

by: WOPRAI

Jonathan Reeder Maintained (BEPC) at Buy with Decreased Target to $37 on, Nov 7th, 2022

by: WOPRAI

Jonathan Reeder Maintained (BEP) at Buy with Decreased Target to $35 on, Nov 7th, 2022

by: WOPRAI

Mani Foroohar Maintained (BEAM) at Buy with Decreased Target to $81 on, Nov 7th, 2022

by: WOPRAI

Raghuram Selvaraju Maintained (BCPC) at Strong Buy with Decreased Target to $152 on, Nov 7th, 2022

by: WOPRAI

Swayampakula Ramakanth Maintained (CDXS) at Strong Buy with Decreased Target to $15 on, Nov 7th, 2022

by: WOPRAI

PJ Juvekar Maintained (CE) at Hold with Decreased Target to $96 on, Nov 7th, 2022

by: WOPRAI

Kevin Steinke Maintained (CCRN) at Buy with Increased Target to $45 on, Nov 7th, 2022

by: WOPRAI

Mark Massaro Maintained (CDNA) at Strong Buy with Decreased Target to $28 on, Nov 7th, 2022

by: WOPRAI

Brett Feldman Maintained (CCOI) at Strong Sell with Decreased Target to $43 on, Nov 7th, 2022

by: WOPRAI

James Sidoti Upgraded (STAA) to Strong Buy on, Nov 7th, 2022

by: WOPRAI

Michael Cyprys Maintained (STEP) at Hold with Increased Target to $30 on, Nov 7th, 2022

by: WOPRAI

Myles Walton Upgraded (SPR) to Hold on, Nov 7th, 2022

by: WOPRAI

Noah Poponak Maintained (SPR) at Strong Buy with Decreased Target to $43 on, Nov 7th, 2022

by: WOPRAI

Kristine Liwag Maintained (SPR) at Sell with Decreased Target to $27 on, Nov 7th, 2022

by: WOPRAI

Ramsey El-Assal Maintained (SQ) at Buy with Decreased Target to $100 on, Nov 7th, 2022

by: WOPRAI

James Fotheringham Maintained (SQ) at Buy with Increased Target to $120 on, Nov 7th, 2022

by: WOPRAI

Matthew Akers Maintained (SPCE) at Sell with Decreased Target to $60 on, Nov 7th, 2022

by: WOPRAI

John Heagerty Upgraded (SPGI) to Buy and Held Target at $386 on, Nov 7th, 2022

by: WOPRAI

Ric Prentiss Maintained (DBRG) at Strong Buy with Decreased Target to $34 on, Nov 7th, 2022

by: WOPRAI

Divya Goyal Downgraded (TIXT) to Hold and Decreased Target to $26 on, Nov 7th, 2022

by: WOPRAI

Ramsey El-Assal Maintained (TIXT) at Buy with Decreased Target to $29 on, Nov 7th, 2022

by: WOPRAI

Keith Bachman Maintained (TIXT) at Buy with Decreased Target to $27 on, Nov 7th, 2022

by: WOPRAI

Ryan Potter Maintained (TIXT) at Strong Buy with Decreased Target to $26 on, Nov 7th, 2022

by: WOPRAI

Jeff Cantwell Maintained (TIXT) at Buy with Decreased Target to $30 on, Nov 7th, 2022

by: WOPRAI

Rob Oliver Maintained (THRY) at Buy with Decreased Target to $34 on, Nov 7th, 2022

by: WOPRAI

Paul Newsome Downgraded (THG) to Hold and Held Target at $144 on, Nov 7th, 2022

by: WOPRAI

Adam Samuelson Maintained (TSN) at Strong Buy with Decreased Target to $97 on, Nov 7th, 2022

by: WOPRAI

David Begleiter Maintained (TSE) at Hold with Increased Target to $25 on, Nov 7th, 2022

by: WOPRAI

Bascome Majors Downgraded (TRN) to Hold and Held Target at $30 on, Nov 7th, 2022

by: WOPRAI

Finian O"Shea Maintained (TRIN) at Hold with Decreased Target to $10 on, Nov 7th, 2022

by: WOPRAI

Andrew Uerkwitz Maintained (TTWO) at Strong Buy and Held Target at $165 on, Nov 7th, 2022

by: WOPRAI

Thomas Blakey Maintained (TWLO) at Buy with Decreased Target to $77 on, Nov 7th, 2022

by: WOPRAI

Ryan Macwilliams Maintained (TWLO) at Hold with Decreased Target to $60 on, Nov 7th, 2022

Ed Arce Maintained (AUPH) at Strong Buy with Decreased Target to $14 on, Nov 7th, 2022

Ed Arce of HC Wainwright & Co., Maintained "Aurinia Pharmaceuticals Inc." (AUPH) at Strong Buy with Decreased Target from $26 to $14 on, Nov 7th, 2022.

Ed has made no other calls on AUPH in the last 4 months.



There are 3 other peers that have a rating on AUPH. Out of the 3 peers that are also analyzing AUPH, 1 agrees with Ed's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Justin Kim of "Oppenheimer" Downgraded from Buy to Hold on, Friday, November 4th, 2022


These are the ratings of the 2 analyists that currently disagree with Ed

  • Douglas Miehm of "RBC Capital" Maintained at Buy with Decreased Target to $10 on, Friday, November 4th, 2022
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $12 on, Friday, November 4th, 2022